Skip to content

Drug interactions

Imatinib + Ranolazine

Severity: Moderate

Imatinib and Ranolazine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ranolazine inhibits P-glycoprotein, which may modestly raise imatinib exposure. Imatinib is also a CYP3A4 inhibitor that could increase ranolazine levels, and both can affect QT, so the combination may add to adverse effects.

What this interaction means in plain words

Imatinib and Ranolazine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Imatinib belongs to Oncology; Ranolazine belongs to Cardiovascular.

Evidence level: Low

Why it happens

P-glycoprotein inhibition by ranolazine may raise imatinib levels, while imatinib CYP3A4 inhibition may raise ranolazine levels.

What to do

Monitor for imatinib adverse effects such as edema, cytopenias and liver enzyme rises, and review the ECG for QT changes. Limit ranolazine to the lowest effective dose.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Imatinib and Ranolazine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Imatinib with Ranolazine?

MediHelp rates the interaction as moderate. Imatinib and Ranolazine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ranolazine inhibits P-glycoprotein, which may modestly raise imatinib exposure. Imatinib is also a CYP3A4 inhibitor that could increase ranolazine levels, and both can affect QT, so the combination may add to adverse effects.

How serious is the interaction between Imatinib and Ranolazine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for imatinib adverse effects such as edema, cytopenias and liver enzyme rises, and review the ECG for QT changes. Limit ranolazine to the lowest effective dose.

What other medicines interact with Ranolazine?

MediHelp also lists interactions of Ranolazine with, for example, Adagrasib, Amobarbital, Apalutamide. The full list is on the Ranolazine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in